Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...

For the first time, a breathing lung model has been made using cells from only one person. Announced on January 1, the development comes from researchers at the Francis Crick Institute in London and ...

A novel 3D-cell culture method enables the rapid production of genetically identical ‘lung buds’ for the investigation of respiratory diseases, providing new insights into the pathogenesis of COVID-19 ...

With recent studies having established the presence of nano and microplastic particles in the respiratory systems of both human and bird populations, new research has modeled what happens when people ...

On average, we breath around 20 times per minute, every minute and every hour, day, week, month and year of our lives. It is one of the first things we do immediately after birth and one of the last ...

Lungs are highly vulnerable to injury and infection due to continuous exposure to inhaled environmental pathogens and particles. As a result, respiratory diseases are a leading cause of disability and ...

A group of scientists have developed a targeted delivery platform that can induce anti-inflammatory cytokine expression in mouse lungs, which helps restrict tissue damage from respiratory infections ...